Financial Statements for Valeant Pharmaceuticals Intl Inc

Search Images Maps Play YouTube News Gmail Drive More »

Help | Sign in

Recent Quotes (30 days)

You have no recent quotes

chg | %

Valeant Pharmaceuticals Intl Inc financials

Watch this stock

Income Statement

Balance Sheet

Cash Flow

View: Quarterly Data | Annual Data

Hide charts

In Millions of USD (except for per share items)	3 months ending 2013-03-31	3 months ending 2012-12-31	3 months ending 2012-09-30	3 months ending 2012-06-30	3 months ending 2012-03-31
Revenue	1,068.36	986.29	884.14	820.09	856.10
Other Revenue, Total	-	-	-	-	-
Total Revenue	1,068.36	986.29	884.14	820.09	856.10
Cost of Revenue, Total	300.33	286.66	230.25	209.77	311.84
Gross Profit	768.02	699.63	653.89	610.32	544.27
Selling/General/Admin. Expenses, Total	241.90	204.70	188.66	185.44	177.29
Research & Development	23.80	20.16	19.17	17.71	22.01
Depreciation/Amortization	326.18	299.49	218.19	210.57	200.64
Interest Expense(Income) - Net Operating	-	-	-	-	-
Unusual Expense (Income)	80.53	291.00	200.73	109.79	82.97
Other Operating Expenses, Total	-	-	-	-	-
Total Operating Expense	972.73	1,102.00	857.00	733.28	794.74
Operating Income	95.63	-115.71	27.14	86.81	61.36
Interest Income(Expense), Net Non-Operating	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Other, Net	-	-	-	-	-
Income Before Tax	-54.79	-274.64	-89.35	-17.06	-13.18
Income After Tax	-27.53	-89.14	7.64	-21.61	-12.92
Minority Interest	-	-	-	-	-
Equity In Affiliates	-	-	-	-	-
Net Income Before Extra. Items	-27.53	-89.14	7.64	-21.61	-12.92
Accounting Change	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Extraordinary Item	-	-	-	-	-
Net Income	-27.53	-89.14	7.64	-21.61	-12.92
Preferred Dividends	-	-	-	-	-
Income Available to Common Excl. Extra Items	-27.53	-89.14	7.64	-21.61	-12.92
Income Available to Common Incl. Extra Items	-27.53	-89.14	7.64	-21.61	-12.92
Basic Weighted Average Shares	-	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-	-
Dilution Adjustment	0.00	0.00	-	0.00	0.00
Diluted Weighted Average Shares	305.76	305.13	311.74	304.82	307.78
Diluted EPS Excluding Extraordinary Items	-0.09	-0.29	0.02	-0.07	-0.04
Diluted EPS Including Extraordinary Items	-	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-	-
Depreciation, Supplemental	-	-	-	-	-
Total Special Items	-	-	-	-	-
Normalized Income Before Taxes	-	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-	-
Normalized Income After Taxes	-	-	-	-	-
Normalized Income Avail to Common	-	-	-	-	-
Basic Normalized EPS	-	-	-	-	-
Diluted Normalized EPS	0.12	0.37	0.61	0.17	0.17

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Revenue	3,546.63	2,463.45	1,181.24	820.43
Other Revenue, Total	-	-	-	-
Total Revenue	3,546.63	2,463.45	1,181.24	820.43
Cost of Revenue, Total	1,038.52	726.83	405.75	218.16
Gross Profit	2,508.11	1,736.62	775.49	602.27
Selling/General/Admin. Expenses, Total	750.82	561.49	276.55	167.63
Research & Development	79.05	65.69	68.31	47.58
Depreciation/Amortization	928.88	557.81	219.76	104.73
Interest Expense(Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	689.75	288.52	353.37	101.17
Other Operating Expenses, Total	-	-	-	-
Total Operating Expense	3,487.02	2,200.34	1,323.73	639.28
Operating Income	59.60	263.12	-142.50	181.15
Interest Income(Expense), Net Non-Operating	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-
Other, Net	-	-	-	-
Income Before Tax	-394.23	-18.00	-236.26	174.96
Income After Tax	-116.03	159.56	-208.19	176.46
Minority Interest	-	-	-	-
Equity In Affiliates	-	-	-	-
Net Income Before Extra. Items	-116.03	159.56	-208.19	176.46
Accounting Change	-	-	-	-
Discontinued Operations	-	-	-	-
Extraordinary Item	-	-	-	-
Net Income	-116.03	159.56	-208.19	176.46
Preferred Dividends	-	-	-	-
Income Available to Common Excl. Extra Items	-116.03	159.56	-208.19	176.46
Income Available to Common Incl. Extra Items	-116.03	159.56	-208.19	176.46
Basic Weighted Average Shares	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-
Dilution Adjustment	0.00	-	0.00	-
Diluted Weighted Average Shares	305.45	326.12	195.81	158.51
Diluted EPS Excluding Extraordinary Items	-0.38	0.49	-1.06	1.11
Diluted EPS Including Extraordinary Items	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	1.28	0.65
Gross Dividends - Common Stock	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-
Depreciation, Supplemental	-	-	-	-
Total Special Items	-	-	-	-
Normalized Income Before Taxes	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-
Normalized Income After Taxes	-	-	-	-
Normalized Income Avail to Common	-	-	-	-
Basic Normalized EPS	-	-	-	-
Diluted Normalized EPS	1.35	1.27	0.55	1.66

In Millions of USD (except for per share items)	As of 2013-03-31	As of 2012-12-31	As of 2012-09-30	As of 2012-06-30	As of 2012-03-31
Cash & Equivalents	413.74	916.09	257.73	395.27	330.48
Short Term Investments	-	4.41	0.00	0.00	1.05
Cash and Short Term Investments	413.74	920.50	257.73	395.27	331.53
Accounts Receivable - Trade, Net	1,054.16	913.84	805.01	611.20	613.56
Receivables - Other	-	-	-	-	-
Total Receivables, Net	1,054.16	913.84	805.01	611.20	613.56
Total Inventory	509.68	531.26	418.25	388.73	373.53
Prepaid Expenses	136.75	125.87	72.21	56.47	52.49
Other Current Assets, Total	255.81	285.99	160.46	178.56	160.82
Total Current Assets	2,370.13	2,777.45	1,713.67	1,630.23	1,531.93
Property/Plant/Equipment, Total - Gross	-	-	-	-	-
Accumulated Depreciation, Total	-	-	-	-	-
Goodwill, Net	5,165.25	5,141.37	3,799.61	3,724.34	3,730.28
Intangibles, Net	9,227.32	9,308.67	8,035.72	8,121.56	7,808.81
Long Term Investments	-	-	-	-	-
Other Long Term Assets, Total	270.80	260.17	146.88	134.29	122.20
Total Assets	17,486.47	17,950.38	14,146.21	14,019.82	13,619.73
Accounts Payable	183.02	227.38	166.69	156.18	156.28
Accrued Expenses	1,071.62	981.28	634.72	600.66	543.31
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	289.68	480.18	207.69	195.15	145.06
Other Current liabilities, Total	101.81	133.90	149.41	97.21	113.28
Total Current Liabilities	1,646.13	1,822.75	1,158.51	1,049.20	957.93
Long Term Debt	10,327.44	10,535.44	7,422.56	7,356.02	6,851.01
Capital Lease Obligations	-	-	-	-	-
Total Long Term Debt	10,327.44	10,535.44	7,422.56	7,356.02	6,851.01
Total Debt	10,617.12	11,015.62	7,630.25	7,551.18	6,996.07
Deferred Income Tax	1,259.90	1,248.31	1,127.23	1,229.03	1,134.31
Minority Interest	-	-	0.00	-	-
Other Liabilities, Total	666.01	626.47	652.73	690.14	600.04
Total Liabilities	13,899.48	14,232.98	10,361.03	10,324.39	9,543.30
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	5,942.54	5,940.65	5,916.67	5,885.23	5,936.77
Additional Paid-In Capital	264.98	267.12	270.18	283.06	284.78
Retained Earnings (Accumulated Deficit)	-2,423.73	-2,370.98	-2,281.83	-2,245.89	-2,115.59
Treasury Stock - Common	-	-	-	-	-
Other Equity, Total	-202.86	-119.78	-119.84	-226.97	-29.31
Total Equity	3,586.99	3,717.40	3,785.18	3,695.43	4,076.43
Total Liabilities & Shareholders' Equity	17,486.47	17,950.38	14,146.21	14,019.82	13,619.73
Shares Outs - Common Stock Primary Issue	-	-	-	-	-
Total Common Shares Outstanding	303.86	303.86	302.90	302.05	304.88

In Millions of USD (except for per share items)	As of 2012-12-31	As of 2011-12-31	As of 2010-12-31	As of 2009-12-31
Cash & Equivalents	916.09	164.11	394.27	114.46
Short Term Investments	4.41	6.34	6.08	9.57
Cash and Short Term Investments	920.50	170.45	400.35	124.03
Accounts Receivable - Trade, Net	769.47	468.54	234.02	99.42
Receivables - Other	-	-	-	-
Total Receivables, Net	913.84	569.27	283.06	112.17
Total Inventory	531.26	355.21	229.58	82.77
Prepaid Expenses	125.87	41.88	26.09	15.38
Other Current Assets, Total	285.99	220.69	81.08	8.54
Total Current Assets	2,777.45	1,357.51	1,020.17	342.89
Property/Plant/Equipment, Total - Gross	636.23	540.03	404.46	221.95
Accumulated Depreciation, Total	-173.51	-125.79	-122.71	-118.10
Goodwill, Net	5,141.37	3,581.51	3,001.38	100.29
Intangibles, Net	9,308.67	7,641.48	6,372.78	1,335.22
Long Term Investments	7.17	0.00	2.08	11.52
Other Long Term Assets, Total	253.00	113.38	116.96	165.52
Total Assets	17,950.38	13,108.12	10,795.12	2,059.29
Accounts Payable	227.38	157.62	101.32	72.02
Accrued Expenses	981.28	527.58	442.11	122.09
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	480.18	111.25	116.90	12.11
Other Current liabilities, Total	133.90	127.82	32.12	42.93
Total Current Liabilities	1,822.75	924.27	692.46	249.15
Long Term Debt	10,535.44	6,539.76	3,478.38	313.98
Capital Lease Obligations	-	-	-	-
Total Long Term Debt	10,535.44	6,539.76	3,478.38	313.98
Total Debt	11,015.62	6,651.01	3,595.28	326.08
Deferred Income Tax	1,248.31	1,188.51	1,436.74	0.00
Minority Interest	-	-	-	-
Other Liabilities, Total	626.47	525.75	276.44	141.79
Total Liabilities	14,232.98	9,178.29	5,884.02	704.92
Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	5,940.65	5,963.62	5,251.73	1,465.00
Additional Paid-In Capital	267.12	276.12	495.04	91.77
Retained Earnings (Accumulated Deficit)	-2,370.98	-2,030.29	-934.51	-245.97
Treasury Stock - Common	-	-	-	-
Other Equity, Total	-119.78	-281.05	98.93	44.29
Total Equity	3,717.40	3,929.83	4,911.10	1,354.37
Total Liabilities & Shareholders' Equity	17,950.38	13,108.12	10,795.12	2,059.29
Shares Outs - Common Stock Primary Issue	-	-	-	-
Total Common Shares Outstanding	303.86	306.37	302.45	158.31

In Millions of USD (except for per share items)	3 months ending 2013-03-31	12 months ending 2012-12-31	9 months ending 2012-09-30	6 months ending 2012-06-30	3 months ending 2012-03-31
Net Income/Starting Line	-27.53	-116.03	-26.88	-34.53	-12.92
Depreciation/Depletion	341.44	986.22	672.76	437.45	215.58
Amortization	-	-	-	-	-
Deferred Taxes	-37.35	-319.60	-127.80	-20.71	-14.86
Non-Cash Items	83.89	359.26	286.29	140.61	49.15
Changes in Working Capital	-105.10	-253.28	-215.71	-100.99	-69.72
Cash from Operating Activities	255.35	656.58	588.66	421.83	167.23
Capital Expenditures	-14.75	-181.13	-90.65	-27.28	-12.98
Other Investing Cash Flow Items, Total	-220.15	-2,784.59	-901.26	-667.24	-205.40
Cash from Investing Activities	-234.90	-2,965.72	-991.92	-694.52	-218.38
Financing Cash Flow Items	-56.61	-155.61	-120.22	-73.82	-32.17
Total Cash Dividends Paid	-	-	-	-	-
Issuance (Retirement) of Stock, Net	-32.33	-257.70	-268.50	-273.70	-103.62
Issuance (Retirement) of Debt, Net	-426.98	3,470.68	883.72	850.46	346.22
Cash from Financing Activities	-515.92	3,057.37	495.00	502.94	210.44
Foreign Exchange Effects	-6.89	3.75	1.87	0.91	7.08
Net Change in Cash	-502.36	751.98	93.62	231.16	166.37
Cash Interest Paid, Supplemental	-	421.02	-	-	-
Cash Taxes Paid, Supplemental	-	41.42	-	-	-

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Net Income/Starting Line	-116.03	159.56	-208.19	176.46
Depreciation/Depletion	986.22	612.60	254.50	149.26
Amortization	-	-	-	-
Deferred Taxes	-319.60	-222.96	-55.40	-16.00
Non-Cash Items	359.26	228.39	294.15	52.71
Changes in Working Capital	-253.28	-137.12	-21.86	-1.53
Cash from Operating Activities	656.58	640.47	263.19	360.90
Capital Expenditures	-181.13	-385.95	-16.82	-569.25
Other Investing Cash Flow Items, Total	-2,784.59	-2,422.56	245.76	-173.52
Cash from Investing Activities	-2,965.72	-2,808.51	228.94	-742.77
Financing Cash Flow Items	-155.61	-225.02	-55.87	-26.67
Total Cash Dividends Paid	0.00	0.00	-356.29	-147.15
Issuance (Retirement) of Stock, Net	-257.70	-597.50	-1.71	0.87
Issuance (Retirement) of Debt, Net	3,470.68	2,770.69	200.58	350.00
Cash from Financing Activities	3,057.37	1,948.16	-213.28	177.05
Foreign Exchange Effects	3.75	-10.29	0.96	1.74
Net Change in Cash	751.98	-230.16	279.81	-203.08
Cash Interest Paid, Supplemental	421.02	247.88	37.72	4.18
Cash Taxes Paid, Supplemental	41.42	45.40	26.30	12.14